|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/445 | |
| A61K 38/47 | |||
| A61P 3/00 |
| (11) | Number of the document | 2683382 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12758017.3 |
| Date of filing the European patent application | 2012-03-08 | |
| (97) | Date of publication of the European application | 2014-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/028260 |
| Date | 2012-03-08 |
| (87) | Number | WO 2012/125402 |
| Date | 2012-09-20 |
| (30) | Number | Date | Country code |
| 201161451798 P | 2011-03-11 | US | |
| 201161578201 P | 2011-12-20 | US | |
| 201261596165 P | 2012-02-07 | US |
| (72) |
GREENE, Douglas, Stuart, US
VALENZANO, Kenneth, Joseph, US
|
| (73) |
Amicus Therapeutics, Inc.,
1 Cedar Brook Drive, Cranbury, NJ 08512,
US
|
| (54) | DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE |
| DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE |